Corcept Therapeutics Incorporated shares owned by Victory Capital Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Victory Capital Management
from 13F filings
Historical chart of Victory Capital Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Victory Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Corcept Therapeutics Incorporated by Victory Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.1M | 61k | 83.11 |
| 2025-06-30 | $6.0M | 82k | 73.40 |
| 2025-03-31 | $11M | 93k | 114.22 |
| 2024-12-31 | $3.8M | 75k | 50.39 |
| 2024-09-30 | $1.9M | 42k | 46.28 |
| 2024-06-30 | $911k | 28k | 32.49 |
| 2024-03-31 | $878k | 35k | 25.19 |
| 2023-12-31 | $1.5M | 47k | 32.48 |
| 2023-09-30 | $2.2M | 79k | 27.25 |
| 2023-06-30 | $4.0M | 179k | 22.25 |
| 2023-03-31 | $3.9M | 181k | 21.66 |
| 2022-12-31 | $3.7M | 171k | 21.88 |
| 2022-09-30 | $3.1M | 122k | 25.64 |
| 2022-06-30 | $3.0M | 127k | 23.78 |
| 2022-03-31 | $2.9M | 132k | 22.04 |
| 2021-12-31 | $2.7M | 134k | 19.80 |
| 2021-09-30 | $2.6M | 131k | 19.68 |
| 2021-06-30 | $1.2M | 54k | 21.99 |
| 2021-03-31 | $1.2M | 51k | 23.80 |
| 2020-12-31 | $1.8M | 70k | 26.16 |
| 2020-09-30 | $2.0M | 117k | 17.40 |
| 2020-06-30 | $2.0M | 116k | 16.82 |
| 2020-03-31 | $940k | 79k | 11.89 |
| 2019-12-31 | $814k | 67k | 12.11 |
| 2019-09-30 | $835k | 59k | 14.13 |
| 2019-06-30 | $51k | 4.5k | 11.24 |
| 2019-03-31 | $146k | 12k | 11.75 |
| 2018-12-31 | $257k | 19k | 13.35 |
| 2018-09-30 | $259k | 19k | 14.00 |
| 2018-06-30 | $143k | 9.1k | 15.74 |
| 2018-03-31 | $129k | 7.8k | 16.45 |
| 2017-12-31 | $110k | 6.1k | 17.99 |
| 2017-09-30 | $108k | 5.6k | 19.34 |
More positions owned by Victory Capital Management
View all positions for Victory Capital Management
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated